What are the economic barriers to bioterrirism vaccine development and distribution and the problem of liability exposure?

At this AEI event, panelists will comment on the CDC's future with vaccines, drawing from experiences in public health, policy, and industry.

Members of an Institute of Medicine panel gathered at AEI on December 1 to discus the IOM's recently released report on the growing immunization problem.

Creating a "philosophical" exemption for mandatory vaccination stokes deadly outbreaks of diseases long since thought to be eradicated.

International funders must take a broader focus on the needs of the country where they lend money--or accept that their largesse may backfire.

The current system of supplying vaccines appears to be in a state of crisis. While immunization rates among children are high, there have been periodic shortages of vaccines. In addition, there are few incentives to develop new vaccines, and a declining number of manufacturers. That has raised concerns that we...

Bioterrorism attacks using anthrax occurred almost simultaneously with shortages of widely used vaccines. Because vaccines are essential to biodefense, these two disturbing episodes are ominously linked. The topic of the morning discussion will be whether our recent vaccine shortage is a unique, one-time problem or rather caused by systemic obstacles...

The WHO must address its failures if it is ever to do a better job.